Contact person
Emmanuelle Coutanceau, Partner
Go to profile

Antag Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
May 2017
Website
http://www.antagtherapeutics.com/

The team has developed an expertise around the role of GIP (Gastric inhibitory polypeptide) in diabetes and obesity. ANTAG is a spinout of the University of Copenhagen.

Contact person
Emmanuelle Coutanceau, Partner
Go to profile

Antag Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
May 2017
Website
http://www.antagtherapeutics.com/

The team has developed an expertise around the role of GIP (Gastric inhibitory polypeptide) in diabetes and obesity. ANTAG is a spinout of the University of Copenhagen.

Antag Therapeutics

Investment area
Seed Investments
Region
Europe
Date of investment
May 2017
Website
Visit their website

The team has developed an expertise around the role of GIP (Gastric inhibitory polypeptide) in diabetes and obesity. ANTAG is a spinout of the University of Copenhagen.

Contact person
Emmanuelle Coutanceau, Partner
Go to profile